KATIE DAVIS: Open Payments
NPI 1548576531 · GREENDALE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,474 in 66 payments from 22 companies in 2025. Trend: 2023 $831 · 2024 $1,323 · 2025 $1,474
Food & beverage: $1,474
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $351 |
| GENZYME CORPORATION | 3 | $181 |
| Vanda Pharmaceuticals Inc. | 5 | $110 |
| Alkermes, Inc. | 1 | $104 |
| CSL Behring | 4 | $90 |
| Lilly USA, LLC | 3 | $77 |
| Exact Sciences Corporation | 3 | $68 |
| PFIZER INC. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Novo Nordisk Inc | 3 | $54 |
Products named: VRAYLAR, DUPIXENT, FANAPT, LYBALVI, REXULTI, Cologuard Collection Kit, JARDIANCE, UBRELVY.
Industry payments across IN — which companies pay providers there.
